BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 16276461)

  • 1. Transfusion-transmitted infection in hemophilia in developing countries.
    Yee TT; Lee CA
    Semin Thromb Hemost; 2005 Nov; 31(5):527-37. PubMed ID: 16276461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prevention of transfusion-associated virus infections in hemophilic patients needing replacement therapy].
    Meili EO
    Beitr Infusionsther; 1989; 24():46-55. PubMed ID: 2481548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Legal, financial, and public health consequences of transfusion-transmitted hepatitis C virus in persons with haemophilia.
    Angelotta C; McKoy JM; Fisher MJ; Buffie CG; Barfi K; Ramsey G; Frohlich L; Bennett CL
    Vox Sang; 2007 Aug; 93(2):159-65. PubMed ID: 17683360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hepatitis C virus infection in patients with hemophilia].
    Baptista González HA
    Rev Gastroenterol Mex; 2002 Oct; 67 Suppl 2():S75-9. PubMed ID: 12712860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical uses of plasma and plasma fractions: plasma-derived products for hemophilias A and B, and for von Willebrand disease.
    Josephson CD; Abshire TC
    Best Pract Res Clin Haematol; 2006; 19(1):35-49. PubMed ID: 16377540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consensus opinion for the selection and use of therapeutic products for the treatment of haemophilia in Spain.
    Batlle J; Villar A; Liras A; Alonso C; Altisent C; Brito D; Moreno M; Lucía F; Sedano C; Prieto M; Calvente N; Aznar JA; Jiménez V; Soriano V; Martorell JR; Iruín G; Bergua JM; Aguilar C
    Blood Coagul Fibrinolysis; 2008 Jul; 19(5):333-40. PubMed ID: 18600079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond HIV, HBV and HCV--how to deal with other viruses?
    Minor PD
    Dev Biol (Basel); 2002; 108():15-9. PubMed ID: 12220138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemophilia care in Zimbabwe.
    Adewuyi JO; Coutts AM; Levy L; Lloyd SE
    Cent Afr J Med; 1996 May; 42(5):153-6. PubMed ID: 8771937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and risk factors of hepatitis C virus, hepatitis B virus, and human immunodeficiency virus in multiply transfused recipients in Mexico.
    Calderón GM; González-Velázquez F; González-Bonilla CR; Novelo-Garza B; Terrazas JJ; Martínez-Rodríguez ML; Cortés-Márquez SR; Blanco-Flores JP; Rodríguez-Rodríguez A; Del Campo MA; Cortés-Gómez R; Mejía-Bocanegra MG
    Transfusion; 2009 Oct; 49(10):2200-7. PubMed ID: 19538543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of hepatitis C in hemophiliacs.
    Franchini M; Nicolini N; Capra F
    Am J Hematol; 2006 Sep; 81(9):696-702. PubMed ID: 16838339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The natural history of hepatitis C virus infection in Italian patients with von Willebrand's disease: a cohort study.
    Federici AB; Santagostino E; Rumi MG; Russo A; Mancuso ME; Soffredini R; Mannucci PM; Colombo M
    Haematologica; 2006 Apr; 91(4):503-8. PubMed ID: 16585016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
    Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
    Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current safety of clotting factor concentrates.
    Epstein JS; Fricke WA
    Arch Pathol Lab Med; 1990 Mar; 114(3):335-40. PubMed ID: 2407224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The natural history of childhood-acquired hepatitis C infection in patients with inherited bleeding disorders.
    Posthouwer D; Fischer K; van Erpecum KJ; Mauser-Bunschoten EP
    Transfusion; 2006 Aug; 46(8):1360-6. PubMed ID: 16934072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expanding hemophilia care in developing countries.
    O'Mahony B; Black C
    Semin Thromb Hemost; 2005 Nov; 31(5):561-8. PubMed ID: 16276465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood-borne viral infections.
    Gürtler L
    Blood Coagul Fibrinolysis; 1994 Dec; 5 Suppl 3():S5-10; discussion S11-2. PubMed ID: 7749048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B and C virus infections in patients with hemophilia in Zahedan, southeast Iran.
    Sharifi-Mood B; Eshghi P; Sanei-Moghaddam E; Hashemi M
    Saudi Med J; 2007 Oct; 28(10):1516-9. PubMed ID: 17914511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact and management of hepatitis B and hepatitis C virus co-infection in HIV patients.
    Kumar R; Singla V; Kacharya Sk
    Trop Gastroenterol; 2008; 29(3):136-47. PubMed ID: 19115605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C at the israeli national hemophilia center.
    Maor Y; Bashari D; Kenet G; Lalezari S; Lubetsky A; Luboshitz J; Schapiro JM; Avidan B; Bar-Meir S; Martinowitz U
    Haemophilia; 2006 Jan; 12(1):68-74. PubMed ID: 16409178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging and receding risks of therapeutic regimens for haemophilia.
    Farrugia A; Manno CS; Evatt BL
    Haemophilia; 2004 Oct; 10 Suppl 4():47-54. PubMed ID: 15479372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.